MoneyWorks4Me

Roselabs Group's Firms invests over Rs 400 crore to set up PFS making facility at Ahmedabad

19 Jun 2013 Evaluate

Roselabs Group's Firms, Roselabs Bioscience and Roselabs Polymers have invested over Rs 400 crore to set up 'pre-filled syringes' (PFS) making facility near Ahmedabad with a capacity to manufacture 8 lakh syringes per day. The company’s facility near Ahmedabad has capabilities to make both glass and polymer (Cyclic Olefin Copolymer) syringes.

The two companies, which target Rs 100 crore turnover by this fiscal year end, so far, have commercialized 26 products in the PFS segment in India.

Roselab Biosciences, which manufactures glass pre-filled syringes, pre-fillable syringes, formulations and cytotoxic Active Pharmaceutical Ingredients (API) and Roselab Polymers, which delivers sterile, clean and ready to fill pre-fillable polymer syringes, are the group companies of Roselabs.

Peers